A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration

被引：0
|
作者：
Dae Hyun Park
Hae Jung Sun
Sung Jin Lee
机构：
[1] Soonchunhyang University Hospital,Department of Opthalmology, College of Medicine
来源：
International Ophthalmology | 2017年 / 37卷
关键词：
Bevacizumab; Ranibizumab; Aflibercept; Anti-vascular endothelial growth factor (anti-VEGF); Neovascular age-related macular degeneration (AMD);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1205 / 1214
页数：9
相关论文
共 50 条
  • [31] Response to the letter to the editor: Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration
    Cheolmin Yun
    Jaeryung Oh
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 2067 - 2067
  • [32] Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
    Patel, K. H.
    Chow, C. C.
    Rathod, R.
    Mieler, W. F.
    Lim, J. I.
    Ulanski, L. J., II
    Leiderman, Y. I.
    Arun, V.
    Chau, F. Y.
    [J]. EYE, 2013, 27 (05) : 664 - 667
  • [33] Intravitreal aflibercept outcomes in patients with persistent retinal fluid with prior bevacizumab or ranibizumab treatment for neovascular age-related macular degeneration
    Griffin, David
    Richmond, Preston
    Olson, John
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [34] Response to the letter to the editor: Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration
    Yun, Cheolmin
    Oh, Jaeryung
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (10) : 2067 - 2067
  • [35] Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration
    Kent, Jerrod S.
    Iordanous, Yiannis
    Mao, Alex
    Powell, Anne-Marie
    Kent, Shefalee Shukla
    Sheidow, Tom G.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2012, 47 (02): : 159 - 164
  • [36] Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
    Avery, RL
    Pieramici, DJ
    Rabena, MD
    Castellarin, AA
    Nasir, MA
    Giust, MJ
    [J]. OPHTHALMOLOGY, 2006, 113 (03) : 363 - 372
  • [37] Comparison of Outcomes When Switching Treatment From Intravitreal Bevacizumab to Ranibizumab in Neovascular Age-Related Macular Degeneration
    Kent, J. S.
    Lordanous, Y.
    Mao, A.
    Shukla, S.
    Sheidow, T.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [38] Angiographic Regression Patterns After Intravitreal Ranibizumab Injections for Neovascular Age-Related Macular Degeneration
    Thi Ha Chau Tran
    Querques, Giuseppe
    Forzy, Gerard
    Souied, Eric H.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING, 2011, 42 (06) : 498 - 508
  • [39] Recommencing Intravitreal Ranibizumab Injections for Neovascular Age-Related Macular Degeneration in Patients Following Endophthalmitis
    Sharma, Hannah
    Routledge, Claire
    Elaraoud, Ibtesam
    Mitra, Arijit
    Mushtaq, Bushra
    Lip, Peck-Lin
    Elsherbiny, Samer
    [J]. OPHTHALMOLOGICA, 2016, 236 : 17 - 17
  • [40] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Alaa Din Abdin
    Shady Suffo
    Fatima Asi
    Achim Langenbucher
    Berthold Seitz
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1671 - 1677
12345